These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Predictive and prognostic markers in cancer. Hayes D; Padnos SB Clin Adv Hematol Oncol; 2011 Feb; 9(2):130-2. PubMed ID: 22379660 [No Abstract] [Full Text] [Related]
5. Molecular markers for cancer prognosis and treatment: have we struck gold? Nowsheen S; Aziz K; Panayiotidis MI; Georgakilas AG Cancer Lett; 2012 Dec; 327(1-2):142-52. PubMed ID: 22120674 [TBL] [Abstract][Full Text] [Related]
6. The quest for reliable biomarkers to identify new and recurrent cancer. Sauter ER Biomark Med; 2012 Oct; 6(5):561-2. PubMed ID: 23075234 [No Abstract] [Full Text] [Related]
7. [Novel tumor markers-circulating miRNA]. Xie L; Qian XP; Liu BR Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):641-2. PubMed ID: 22340041 [No Abstract] [Full Text] [Related]
8. miRNAs as molecular biomarkers of cancer. Fabbri M Expert Rev Mol Diagn; 2010 May; 10(4):435-44. PubMed ID: 20465498 [TBL] [Abstract][Full Text] [Related]
10. Section I: integrating laboratory medicine with tissue specimens. Fisher KE; Smith GH; Neill SG; Rossi MR Curr Probl Cancer; 2014; 38(5):144-58. PubMed ID: 25239562 [No Abstract] [Full Text] [Related]
11. Cancer biomarkers--a good start. Little S MLO Med Lab Obs; 2009 May; 41(5):18, 20. PubMed ID: 19526892 [No Abstract] [Full Text] [Related]
12. [Molecular markers having a prognostic or therapeutic value in cancer]. Brousset P Ann Pathol; 2008 Nov; 28 Spec No 1(1):S69-70. PubMed ID: 18984307 [No Abstract] [Full Text] [Related]
13. [Molecular targeted cancer therapy and genetic tests --chairman's introductory remarks]. Hinoda Y Rinsho Byori; 2012 Oct; 60(10):967-8. PubMed ID: 23323461 [TBL] [Abstract][Full Text] [Related]
14. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies. Corsini LR; Bronte G; Terrasi M; Amodeo V; Fanale D; Fiorentino E; Cicero G; Bazan V; Russo A Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S103-9. PubMed ID: 22443195 [TBL] [Abstract][Full Text] [Related]
15. Biomarkers and molecular epidemiology--present state and future trends: concluding remarks. Kyrtopoulos SA; Sarrif A; Elliott BM; Schoket B; Demopoulos NA Mutat Res; 2006 Aug; 600(1-2):77-8. PubMed ID: 16806291 [No Abstract] [Full Text] [Related]
16. Cancer: caught in time. Spinney L Nature; 2006 Aug; 442(7104):736-8. PubMed ID: 16915260 [No Abstract] [Full Text] [Related]
17. Cancer proteomics. Tan HT; Lee YH; Chung MC Mass Spectrom Rev; 2012; 31(5):583-605. PubMed ID: 22422534 [TBL] [Abstract][Full Text] [Related]
18. Y-box binding protein 1--a prognostic marker and target in tumour therapy. Kosnopfel C; Sinnberg T; Schittek B Eur J Cell Biol; 2014; 93(1-2):61-70. PubMed ID: 24461929 [TBL] [Abstract][Full Text] [Related]
19. Is there a role of Eastern Europe in cancer biomarkers for personalized cancer medicine? Berindan-Neagoe I; Paradiso A Cancer Biomark; 2014; 14(2-3):85-6. PubMed ID: 24878808 [No Abstract] [Full Text] [Related]
20. Genomic microarrays in cancer molecular diagnostics: just biomarker discovery tools or future bedside clinical assays? Ross JS Expert Rev Mol Diagn; 2005 Nov; 5(6):837-8. PubMed ID: 16255622 [No Abstract] [Full Text] [Related] [Next] [New Search]